Tag: HRS 2024
HRS 2024: FARADISE registry “underscores” safety and efficacy of Farapulse PFA...
Insights from the FARADISE registry, studying real-world outcomes from more than 1,000 patients to have undergone catheter ablation for paroxysmal and non-paroxysmal atrial fibrillation...
Mediterranean diet reduces risk of arrhythmia recurrence after ablation for paroxysmal...
Patients with previous paroxysmal atrial fibrillation (AF) who follow a Mediterranean diet enriched with extra-virgin olive oil after a catheter ablation procedure saw improved...
HRS 2024: “Noteworthy” results from MODULAR ATP trial detail use of...
Six-month results from the ongoing pivotal MODULAR ATP clinical trial assessing the Boston Scientific’s mCRM modular cardiac rhythm management (CRM) system were presented at...
HRS 2024: Late-breaking data explore safety and efficacy of Varipulse PFA...
Late-breaking results from the pivotal phase of the admIRE pivotal clinical trial, alongside results from the VIRTUE study—both assessing the Varipulse (Biosense Webster) pulsed...